Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.

Publikation

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.

Wissenschaftlicher Artikel/Review - 20.08.2018

Peiseler Moritz, Reiners David, Pinnschmidt Hans O, Sebode Marcial, Jung Franziska, Hartl Johannes, Zenouzi Roman, Ehlken Hanno, Groth Stefan, Schachschal Guido, Rösch Thomas, Weiler-Normann Christina, Lohse Ansgar W, Schramm Christoph

Zitation

Peiseler M, Reiners D, Pinnschmidt H, Sebode M, Jung F, Hartl J, Zenouzi R, Ehlken H, Groth S, Schachschal G, Rösch T, Weiler-Normann C, Lohse A, Schramm C. Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis. PloS one 2018; 13:e0202686.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

PloS one 2018; 13

Veröffentlichungsdatum

20.08.2018

eISSN (Online)

1932-6203

Seiten

e0202686

Kurzbeschreibung/Zielsetzung

Endoscopic retrograde cholangiography (ERC) is a mainstay of therapy in patients with primary sclerosing cholangitis (PSC) and obstructive cholestasis. Patients with liver cirrhosis have an increased risk of surgical complications and are more susceptible to infections. Since PSC often progresses to cirrhosis, we aimed to assess whether ERC is associated with increased risk of complications in patients with PSC and cirrhosis.